Brief: Genoway Sees 2023 EBITDA Margin Above 20%

genOway SA

16/01/2024 17:08

Jan 16 (Reuters) - Genoway SA  ALGEN.PA :
    * FY TOTAL REVENUE EUR 20.1 MILLION VERSUS EUR 17.0 MILLION
YEAR
AGO
    * WE HAVE SIGNIFICANTLY IMPROVED OUR PROFITABILITY, WITH AN
EBITDA
MARGIN ABOVE 15% SINCE 2022 AND EXPECTED TO BE ABOVE 20% IN 2023

Source text for Eikon:  ID:nACT83728 
Further company coverage:  ALGEN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))